GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Total Current Liabilities

Molekule Group (Molekule Group) Total Current Liabilities : $17.30 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Molekule Group's total current liabilities for the quarter that ended in Jun. 2023 was $17.30

Molekule Group Total Current Liabilities Historical Data

The historical data trend for Molekule Group's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Total Current Liabilities Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Total Current Liabilities
0.23 0.67 1.51 4.56

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.78 2.69 4.56 20.39 17.30

Molekule Group Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Molekule Group's Total Current Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=4.448+0.114
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=4.56

Molekule Group's Total Current Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=12.051+4.86
+Other Current Liabilities+Current Deferred Liabilities
=0.385+0
=17.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Molekule Group Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Molekule Group's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Molekule Group (Molekule Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Total Current Liabilities
Comparable Companies
LQWC RAKR VLTO XBRU:UMI ZWS FSS TSE:6370 SZSE:300390 OSTO:MTRS SHSE:600388 SHSE:603279 ATMU TSE:6368 HKSE:00586 SZSE:000544 TSE:7004 ERII BOM:500214 TSE:6013 MIL:GVS
Traded in Other Exchanges
N/A
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Website
https://www.molekule.com
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.
Executives
Ritankar Pal officer: Chief Operating Officer 10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris officer: Chief Commercial Officer 3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld director C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre 10 percent owner
Seth Levine 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p. 10 percent owner C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell 10 percent owner C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona officer: Chief Executive Officer 10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet director 10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410